1. Li X., Lu X., and Xing M. (2012) Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents. Bioorg. Med. Chem. Lett., 22 (11) 3589-3593.
2. Faidallah H. M., Khan K. A., and Asiri A. M. (2011) Synthesis and biological evaluation of new 3-trifluoromethylpyrazolesulfonyl-urea and thiourea derivatives as antidiabetic and antimicrobial agents. J. Fluor. Chem., 132 (2) 131-137.
3. Abdel-Aziz M., Abuo-Rahma G. A., and Hassan, A. A. (2009) Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities. Eur. J. Med. Chem. 44 (9) 3480-3487.
4. Gokulan P. D., Jayakar B., Alagarsam V., and Raja S. V. (2012) Synthesis and pharmacological investigation of 5-substituted-3-methylsulfanyl-1H-pyrazole-4-carboxylic acid ethyl esters as new analgesic and anti-inflammatory agents. Arzneimittelforschung., 62 (10) 457-462.
5. Alam M. M., Marella A., and Akhtar M. (2013) Microwave assisted one pot synthesis of some pyrazole derivatives as a safer anti-inflammatory and analgesic agents. Acta Pol. Pharm., 70 (3) 435-441.
6. El-Sabbagh O. I., Baraka M., Ibrahim S. M., Pannecouque C., Andrei G., Snoeck R., Balzarini J., and Rashad A. A. (2009) Synthesis and antiviral activity of new pyrazole and thiazole derivatives. Eur. J. Med. Chem. 44 (9) 3746-3753.
7. Vijesh A. M., Isloor A. M., Shetty P., Sundershan S., and Fun H. K. (2013) New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents. Eur. J. Med. Chem., 62 (4) 410-415.
8. Das N., Verma A., Shrivastava P. K., and Shrivastava S. K. (2008) Synthesis and biological evaluation of some new aryl pyrazol-3-one derivatives as potential hypoglycemic agents. Indian J. Chem., 47B (10) 1555-1558.
9. James M. N. G., and Watson K. J. (1966) Chemistry of micrococcin P. Part IX. The crystal and molecular structure of micrococcinic acid bis-4-bromoanilide. J Chem Soc Perkin 1., 16, 1361-1371.
10. Ghazzi M. N., Perez J. E., Antonucci T. K., Driscoll J. H., Huang S. M., Faja B. W., and Whitcomb R. W. (1997) Cardiac and glycemic benefits of triglitazone treatment in NIDDM. The troglytazone study group. Diabetes., 46 (3) 433-439.
11. Peter M., and Wolfgang S. (1987) Synthesis of α-amino acids by reaction of t-butyl n-(t-butoxycarbonyl)iminoacetate with C-nucleophiles. Synthesis, 1987 (3) 223-225.
12. Dave C. G., and Shukla M. C. (2000) Pyridopyrimidines: Part IX-synthesis and antibacterial activity of 2-methylthio-6-phenylazo-5,7-dimethylpyrido[2,3-d]pyrimidin-4(3H)-ones. Indian J. Chem., 39B (3) 210-214.
13. Doran W. J., and Shonle H. A. (1938) Dialkyl thiozolidones. J. Org. Chem., 3 (3) 193-197.
14. Menozzi G., Mosti L., Schenone P., Amico M. D., Falciani M., and Filippelli W. (1994) 1-Aryl-1H-pyrazole-5-acetic acids with anti-inflammatory, analgesic and other activities. Farmaco., 49 (2) 115-119.
15. Barot V. M. (1996) Synthesis and antibacterial activity of some new 2-amino- pyrimidines and 2-(1H)pyrimidinones. Asian J. Chem., 8 (4) 802-804.
16. Bhawani S., Maheshwari A., Dak G., Sharma K., and Talesara G. L. (2010) Studies of antimicrobial activities of some 4-thiazolidinone fused pyrimidines, [1,5]-benzodiazepines and their oxygen substituted hydroxylamine derivatives. Indian J. Pharm. Sci., 72 (5) 607-612.
17. Pushkal S., Ritu S., Srivastava S. K., and Srivastava S. D. (2014) Synthesis and biological evaluation of 4-thiazolidinone derivatives as antitubercular and antimicrobial agents. Arabian J. Chem., 7 (5) 657-665.
18. Taranalli A. D., Bhat A. R., Srinivas S., and Saravanan E. (2008) Antiinflammatory, analgesic and antipyretic activity of certain thiazolidinones. Indian J. Pharm. Sci., 70 (2) 159-164.
19. Alexander R. S. (1949) 4-Thiazolidinones. IV. The preparation of some 3-alkyl- amino alkyl-2-aryl derivatives. J. Am. Chem. Soc., 71 (10) 3354-3356.
20. Charanjeet, S., Rajesh A., and Misra S. (1983) Synthesis of 2-thio-3-arylamino/disubsti- tued amino-methyl-4-oxo-5-cinnamylidene-thiazolidines as CNS and anti-inflammatory agents. Current Science., 52 (7) 305-308.
21. Ergenc N., Capan G., Gunay N. S., Oxkirimli S., Gungor M., Oxbey S., and Kendi E. (1999) Synthesis and hypnotic activity of new 4-thiazolidinone and 2-thioxo-4,5-imidazolidinedione derivatives. Arch. Pharm., 332 (10) 343-347.
22. Srinivas A., Nagaraj A., and Sanjeeva Reddy Ch. (2010) Synthesis and in vitro study of methylene-bis-tetrahydro[1,3]thiazolo[4,5.c]isoxazoles as potential nematicidal agents. Eur. J. Med. Chem. 45 (6) 2353-2358.
23. Suresh Kumar G. V., Rajendra Prasad Y., Mallikarjuna B. P., Chandrashekar S. M., and Kishtaiah C. (2010) Synthesis of some novel 2-substituted-5-[isopropylthiazole]clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents. Eur. J. Med. Chem., 45 (5) 2063-2074.
24. Laazrek H. B., Taourirte M., Oulih T., Barascut J. L., Imbach J. L., Pannecouque C., Wintrouw M., and De Clercq E. (2001) Synthesis and anti-HIV activity of new modified 1,2,3-triazole acyclonucleosides. Nucleoside Nucleotides Nucleic Acids., 20 (12) 1949-1960.
25. Buckle D. R., Rockell C. J., Smith H., and Spicer B. A. (1984) Studies on 1,2,3-triazoles: synthesis and antiallergic properties of 9-oxo-1H, 9H-benzothio-pyrano[2,3-d]-1,2,3-triazoles and their S-oxides. J. Med. Chem., 27 (2) 223-227.
26. De las Heras F. G., Alonso R., and Alonso G. (1979) Alkylating nucleosides: synthesis and cytostatic activity of N-glycosyl(halomethyl)-1,2,3-triazoles: A new type of alkylating agent. J. Med. Chem., 22 (5) 496-501.
27. El-Etrawy A. S., and Abdel-Rahman A. A. H. (2010) Synthesis and antiviral evaluation of 1,3-dimethyl-6(1H-1,2,3-triazol-1-yl)pyrimidine-2,4(1H,3H)-dione derivatives. Chem. Heterocycl. Comp., 46, 1105-1108.
28. Holla B. S., Veeranna B., Shivananda M. K., and Poojary B. (2003) Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. Eur. J. Med. Chem., 38 (7-8) 759-767.
29. Chen J., Sun Y., Chai K. Y., Lee J. S., Song M. S., and Quan Z. S. (2007) Synthesis and anticonvulsant evaluation of 4-(4-alkoxylphenyl)-3-ethyl-4H-1,2,4-triazoles as open-chain analogues of 7-alkoxyl-4,5-dihydro[1,2,4]triazolo [4,3-a]quinolines. Bioorg. Med. Chem., 15 (21) 6775-6781.
30. Almajan G. L., Barbucenau S. F., Almajan E. R., Draghici C., and Saramet G. (2009) Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties. Eur. J. Med. Chem., 44 (7) 3083-3089.
31. Palaska E., Sahin G., Kelicen P., Durlu N. T., and Altinok G. (2002) Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco., 57 (2) 101-107.
32. Poulsen S. A., Wilkinson B. L., and Innocenti A.(2008) Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzene sulphonamide derivatives. Bioorg. Med. Chem. Lett. 18 (16) 4624-4627.
33. Joshua S. T., John C. V. R., Michael G. N., Michael P. C., Biswanath De., Lily C. H., and Michael J. J. (2003) The development of new triazole based inhibitors of tumor necrosis factor-α (TNF- α) production. Bioorg. Med. Chem. Lett. 13 (10) 1665-1668.
34. Xu Y., Wang Y., Yan L., Liang R. M., Dai D. D., Tang R. J., Gao P. H., and Jiang Y. Y. (2009) Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: Endogenous ROS Augmentation. J. Proteome Res. 8 (11) 5296-5304.
35. Pasqualotto A. C., and Denning D. W. (2010) New and emerging treatments for fungal infections. J. Antimicrob. Chemother., 61 (1) i19-30.
36. Mellaerts R., Aerts A., Caremans T. P., Vermant J., Van den Mooter G., Martens J. A., and Augustijans P. (2010) Growth of itraconazole nanofibers in supersaturated simulated intestinal fluid. Mol. Pharm., 7 (3), 905-913.
37. Smith J., Safdar N., Knasinski V., Simmons W., Bhavnani M., Ambrose P. G., and Andes D. (2006) Voriconazole therapeutic drug monitoring. Antimicrob. Agents Chemother., 50 (4) 1570-1572.
38. Geria A. N., and Scheinfeld N. S. (2008) Pramiconazole, a triazole compound for the treatment of fungal infections. I Drugs, 11 (9) 661-670.
39. Schiller D. S., Fung H. B. (2008) Posaconazole: an extended-spectrum triazole antifungal agent. Clin. Ther. 29 (9) 1862-1886.
40. Nagaraj A., Srinivas S., and Neelofer R. (2018) Synthesis and biological study of novel triazole analogues of benzothiazepines. Int. J. Curr. Res., 10 (12) 75903-75907.
41. Pavithra G., Vivek H. K., and Ajay Kumar K. (2017) Bioactive formylpyrazole analogues: synthesis, antimicrobial, antioxidant and molecular docking studies. Asian J. Chem., 29 (7) 1549-1554.
42. National Committee for Clinical Laboratory Standards (NCCLs) (1982) Standard methods for dilution antimicrobial susceptibility tests for bacteria, which grows aerobically, Nat. Comm. Lab. Stands. Villanova, pp 242.